AI-based Clinical Trials Solution Provider Market Survey Report 2020 by Size, Share, Trends and Forecasts Research 2028


Market Size – USD 1.24 Billion in 2020, Market Growth – at a CAGR of 21.5%, Market Trends –Increasing integration of AI with big data

.

 

 

The latest research report serves as a perfect example of the precise analysis of the global AI-based clinical trials solution provider market . It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide AI-based Clinical Trials Solution Provider Market industry. The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemic’s aftermath, with respect to this industry

 

The global AI-based clinical trials solution provider market size reached USD 1.24 Billion in 2020 and is expected to register a revenue CAGR of 21.5% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of Artificial Intelligence (AI)-enabled digital technology is a key factor driving global AI-based clinical trials solution provider market revenue growth. Increasing use of AI-enabled digital health technologies coupled with patient support platforms is expected to improve patient engagement and retention throughout study duration as well as after study termination, which is expected to propel revenue growth of the global AI-based clinical trial solution provider market.

 

To get access to the complete report @ https://www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market

 

Covid 19 impact analysis:

 

The report contains updated information about the ongoing COVID-19 pandemic and acts as an accurate analysis of the COVID-19 impact on the AI-based Clinical Trials Solution Provider Market . The report draws attention to the COVID-19 impact on the market and its crucial segments. As per the report, the current pandemic is one of the major contributing elements for the potential decline of the market in the coming years. The business sector has been drastically affected by the pandemic, which has adversely altered the market dynamics and demand trends. Financial difficulties brought by the pandemic have delayed the progress rate of various businesses and disrupted the global supply chains. The report further provides a future impact assessment of the AI-based Clinical Trials Solution Provider Market concerning COVID-19.

Key players in the market include AiCure, LLC, Unlearn.AI, Inc., BioAge Labs Inc., Antidote Technologies, Inc., Saama Technologies Inc., International Machine Business Corporation (IBM), Concentro Health AI, Deep 6 AI Inc., PathAI Inc., and Owkin Inc.

 Global AI-based Clinical Trials Solution Provider Market Geographical Landscape - Synopsis:

  • The report closely studies the growth trajectory of the global AI-based Clinical Trials Solution Provider Market . It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East Africa.
  • The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
  • Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.

Emergen Research has segmented the global AI-based clinical trials solution provider market on the basis of clinical trial phase, therapeutic application, end-use, and region:

Clinical Trial Phase Outlook (Revenue, USD Billion; 2018–2028)

  • Phase-I
  • Phase-II
  • Phase-III

Therapeutic Application Outlook (Revenue, USD Billion; 2018–2028)

  • Cancer
  • Cardiovascular Disease
  • Neurological Disease
  • Metabolic Disease
  • Infectious Disease
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Pharmaceuticals
  • Academia
  • Contract Research Organizations (CROs)

 

 Report Highlights:

 

  • The report conducts a comparative assessment of the leading market players participating in the global AI-based Clinical Trials Solution Provider Market .
  • The report marks the notable developments that have recently taken place in the AI-based Clinical Trials Solution Provider Market tindustry
  • It details on the strategic initiatives undertaken by the market competitors for business expansion.
  • It closely examines the micro- and macro-economic growth indicators, as well as the essential elements of the AI-based Clinical Trials Solution Provider Market value chain.
  • The repot further jots down the major growth prospects for the emerging market players in the leading regions of the market.

 

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Find similar reports @

Topical Drug Delivery @ https://www.emergenresearch.com/industry-report/topical-drug-delivery-market

Joint Reconstruction @ https://www.emergenresearch.com/industry-report/joint-reconstruction-market

Plant Genomics @ https://www.emergenresearch.com/industry-report/plant-genomics-market

Electrotherapy Market @ https://www.emergenresearch.com/industry-report/electrotherapy-market

Blood Pressure Monitoring Devices @ https://www.emergenresearch.com/industry-report/blood-pressure-monitoring-devices-market

Contact Lenses @ https://www.emergenresearch.com/industry-report/contact-lenses-market

Nanotechnology  @ https://www.emergenresearch.com/industry-report/nanotechnology-market

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

Comments